{
  "id": 1762,
  "text": "Vermorken et al.1667 found that the addition of bleomycin, vindesine, and mitomycin C to cisplatin had no impact in survival as compared to cisplatin alone in patients who had histologically confirmed advanced (FIGO stage IVB) or recurrent cervical cancer not suitable for curative treatment woth surgery and/or radiotherapy even if the combination regimen induced a significantly higher response rate than cisplatin alone ( $4 2 \\%$ versus $2 5 \\%$ $\\mathrm { p } = 0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Vermorken et al.1667 found that the addition of bleomycin, vindesine, and mitomycin C to cisplatin had no impact in survival as compared to cisplatin alone in patients who had histologically confirmed advanced (FIGO stage IVB) or recurrent cervical cancer not suitable for curative treatment woth surgery and/or radiotherapy even if the combination regimen induced a significantly higher response rat\n\n<question>: ",
  "ChatGPT_response_0": "根据研究，对于已经确认患有晚期（FIGO IVB期）或复发的宫颈癌，对于不能接受手术和/或放疗治疗的患者来说，添加博莱霉素、长春新碱和丝裂霉素C到顺铂中，并未对生存率产生影响。尽管这种组合方案相较于仅使用顺铂在诱导反应率方面表现出较高的响应率（42％对25％），但依然未对患者的生存率产生显著影响。因此，在治疗这类病例时，需要结合患者的具体情况，综合考虑治疗方案的选择。",
  "query": "对于已经确认患有晚期（FIGO IVB期）或复发的宫颈癌，对于不能接受手术和/或放疗治疗的患者来说，添加博莱霉素、长春新碱和丝裂霉素C到顺铂中对生存率是否有影响？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于已经确认患有晚期（FIGO IVB期）或复发的宫颈癌，对于不能接受手术和/或放疗治疗的患者来说，添加博莱霉素、长春新碱和丝裂霉素C到顺铂中对生存率是否有影响？\n\n<reference text>: Vermorken et al.1667 found that the addition of bleomycin, vindesine, and mitomycin C to cisplatin had no impact in survival as compared to cisplatin alone in patients who had histologically confirmed advanced (FIGO stage IVB) or recurrent cervical cancer not suitable for curative treatment woth surgery and/or radiotherapy even if the combination regimen induced a significantly higher response rate than cisplatin alone ( $4 2 \\%$ versus $2 5 \\%$ $\\mathrm { p } = 0 .\n\n<reply>: ",
  "response": "根据研究，对于已经确认患有晚期（FIGO IVB期）或复发的宫颈癌，对于不能接受手术和/或放疗治疗的患者来说，添加博莱霉素、长春新碱和丝裂霉素C到顺铂中，并未对生存率产生影响。尽管这种组合方案相较于仅使用顺铂在诱导反应率方面表现出较高的响应率（42％对25％），但依然未对患者的生存率产生显著影响。因此，在治疗这类病例时，需要结合患者的具体情况，综合考虑治疗方案的选择。"
}